500 patients67,039 observations150 daysLIVE
Simulate first, then a human deploys. LIFE OS never deploys on its own.

Interventions

Synthetic demo data
What is working among similar responders
Outcomes of every action among the 284 trajectories most similar to P-03166. Sorted by evidence weight (n × improved share).
n = accepted instances
ActionnImprovedMean effectOnsetThis patient
GI-04 GI Support Protocol33
73%
−19%8 deligible · 57%Simulate
ME-01 Monitoring Escalation11
100%
−3%3 dnot indicatedSimulate
DT-01 Dosing / Timing Recommendation11
82%
−16%5 deligible · 59%Simulate
SC-12 Supportive Compound8
100%
−17%6 dnot indicatedSimulate
NP-02 Dietary Support Protocol14
57%
−14%10 deligible · 59%Simulate
HY-01 Hydration Protocol8
63%
−17%4 deligible · 59%Simulate
CR-01 Clinician Review4
100%
−19%5 dalready triedSimulate
BR-03 Behavioural Recommendation2
100%
−12%7 deligible · 59%Simulate
AD-05 Adherence Support8
25%
−7%5 deligible · 59%Simulate
Create intervention
Cohort
1 patients · patient P-03166
Enforcement in the companion
Before deployment
simulation
Save cohortCancel

Campaigns

Nothing deployed yet in ONX-7.

Action catalogue

GI-04Nutritional protocol
GI Support Protocol GI-04
symptom −31% · persistence +17% · onset 8 d
SC-12Supportive compound
Supportive Compound SC-12
symptom −18% · persistence +11% · onset 6 d
NP-02Nutritional protocol
Dietary Support Protocol NP-02
symptom −28% · persistence +9% · onset 10 d
HY-01Hydration protocol
Hydration Protocol HY-01
symptom −14% · persistence +6% · onset 4 d
ME-01Monitoring escalation
Monitoring Escalation ME-01
symptom −5% · persistence +12% · onset 3 d
BR-03Behavioural recommendation
Behavioural Recommendation BR-03
symptom −10% · persistence +10% · onset 7 d
CR-01Clinician review
Clinician Review CR-01
symptom −12% · persistence +15% · onset 5 d
AD-05Adherence support
Adherence Support AD-05
symptom −2% · persistence +14% · onset 5 d
DT-01Dosing / timing recommendation
Dosing / Timing Recommendation DT-01
symptom −16% · persistence +8% · onset 5 d